Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Periodontal Treatment Impact on Hepcidin and Hemoglobin
NCT02641210Phase 4Completed
- Sponsor
- Universidade Federal do Maranhão
- Start
- Jan 2015
- Primary completion
- Jun 2015
01
Overview
Phase 4, open-label trial in chronic periodontitis, sponsored by Universidade Federal do Maranhão. Primary endpoint: Hepcidin serum level at 90 days. Started Jan 2015; status: completed.
02
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT02641210.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02641210.